Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design

Published 2016 View Full Article

Authors

Keywords

Cenicriviroc, Non-alcoholic steatohepatitis, Non-alcoholic fatty liver, Liver fibrosis, Metabolic syndrome, Type 2 diabetes mellitus

Journal

Contemporary Clinical Trials

Volume 47, Issue -, Pages 356-365

Publisher

Elsevier BV

Online

2016-03-02

DOI

10.1016/j.cct.2016.02.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.